T cell activation in rheumatoid synovium is B cell dependent

S Takemura, PA Klimiuk, A Braun… - The Journal of …, 2001 - journals.aai.org
Rheumatoid arthritis results from a T cell-driven inflammation in the synovial membrane that
is frequently associated with the formation of tertiary lymphoid structures. The significance of …

Tissue cytokine patterns distinguish variants of rheumatoid synovitis.

PA Klimiuk, JJ Goronzy, RD Beckenbaugh… - The American journal …, 1997 - ncbi.nlm.nih.gov
… All tissue samples were reviewed by one pathologist (J. Bjornsson) whowas unaware of
any clinical, serological, or immunohistological findings. To control for patchiness of the …

[HTML][HTML] Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis

HL Rittner, V Hafner, PA Klimiuk… - The Journal of …, 1999 - Am Soc Clin Investig
Giant cell arteritis (GCA) is a systemic vasculitis preferentially affecting large and medium-sized
arteries. Inflammatory infiltrates in the arterial wall induce luminal occlusion with …

Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis

PA Klimiuk, S Sierakowski, R Latosiewicz… - Annals of the …, 2002 - ard.bmj.com
PA Klimiuk1, … Kuryliszyn-Moskal A, Bernacka K, Klimiuk PA. Circulating intercellular
adhesion molecule 1 in rheumatoid arthritis - relationship to systemic vasculitis and microvascular …

Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to …

A Kuryliszyn-Moskal, PA Klimiuk, S Sierakowski - Clinical rheumatology, 2005 - Springer
Systemic sclerosis (SSc) is a chronic, multisystemic, autoimmune disease characterised by
vascular changes and varying degrees of fibrosis of the skin and visceral organs. Organ …

Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active …

SB Cohen, A Alonso-Ruiz, PA Klimiuk… - Annals of the …, 2018 - ard.bmj.com
… Piotr A Klimiuk3, … system; Almac Clinical Technologies, Souderton, Pennsylvania, USA)
included stratification according to region (Asia, EU, Latin America, USA) and prior exposure to a …

Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent

PA Klimiuk, H Yang, JJ Goronzy, CM Weyand - Clinical immunology, 1999 - Elsevier
In rheumatoid arthritis, T lymphocytes have been proposed to play a pivotal role in the disease
process, but they have also been considered to simply represent an epiphenomenon in a …

Long-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active …

SB Cohen, N Czeloth, E Lee, PA Klimiuk… - Expert Opinion on …, 2019 - Taylor & Francis
Objective: To evaluate long-term safety, efficacy, and immunogenicity of BI 695501 in
patients with moderately-to-severely active rheumatoid arthritis (RA) who have completed …

Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes

CM Weyand, PA Klimiuk, JJ Goronzy - Springer seminars in …, 1998 - Springer
… that patients with rheumatoid factor (RF)-negative (seronegative) RA were characterized
by an enrichment of both the HLA-DRB 1"04 and *01 alleles [65]. In contrast, 90% of patients …

Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells

AN Vallejo, LO Mügge, PA Klimiuk… - The Journal of …, 2000 - journals.aai.org
Thrombospondin-1 (TSP) is a transiently expressed matricellular protein known to promote
chemotaxis of leukocytes to inflammatory sites. However, TSP and its receptor CD36 are …